Rainfall Health vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $15M Series A (Feb 2026). Built specifically for CMS TEAM model launching January 2026 — mandatory episodic payment reform for 5 major surgical procedures. Up to $100M revenue impact per health system.
About
Rainfall Health is an AI platform built specifically for the CMS Transforming Episode Accountability Model (TEAM), which took effect January 1, 2026 — mandatory episodic payment reform requiring participating hospitals to manage the total cost and quality of care for 90 days following five major surgical procedures: lower extremity joint replacement, surgical hip fracture, spinal fusion, coronary artery bypass graft, and major bowel procedures.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.